Funding and Future Plans
The discussion reveals the intricate relationship between BioNTech and the German government, highlighting that much of their research funding comes from taxpayer money. BioNTech is not just resting on its laurels; they are actively pursuing new projects, including the ambitious goal of using mRNA technology to combat cancer. The conversation hints at a complex web of interests and potential profits that raises questions about accountability and transparency in the biotech industry.In this clip
From this podcast
Doc Malik
#181 - Spike Protein
Related Questions